Perioperative Considerations for Patients Treated with Bleomycin
- 1 April 1991
- Vol. 99 (4) , 993-999
- https://doi.org/10.1378/chest.99.4.993
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Alterations in pulmonary protective enzymes following systemic bleomycin treatment in miceBiochemical Pharmacology, 1988
- Bleomycin Causes Alveolar Macrophages from Cigarette Smokers to Release Hydrogen PeroxideThe Lancet Healthy Longevity, 1988
- Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.Thorax, 1987
- Risk Factors of Anesthesia and Surgery in Bleomycin-Treated PatientsJournal of Urology, 1983
- Pulmonary toxicity of antineoplastic agents: Anaesthetic and postoperative implicationsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1983
- Complications of Retroperitoneal Lymph Node DissectionJournal of Urology, 1981
- Pulmonary toxicity after radiation and bleomycin: A reviewInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.BMJ, 1978
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- MECHANISM OF ACTION OF BLEOMYCIN. STUDIES WITH THE GROWING CULTURE OF BACTERIAL AND TUMOR CELLSThe Journal of Antibiotics, 1968